Sandoz Group AG (VIE:SDZ)

Austria flag Austria · Delayed Price · Currency is EUR
72.04
-2.08 (-2.81%)
Last updated: Mar 3, 2026, 1:00 PM CET
37.17%
Market Cap 32.09B
Revenue (ttm) 9.50B
Net Income (ttm) 778.45M
Shares Out n/a
EPS (ttm) 1.78
PE Ratio 41.23
Forward PE 21.47
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 304
Open 73.40
Previous Close 74.12
Day's Range 72.04 - 73.40
52-Week Range 52.52 - 78.84
Beta n/a
RSI 56.36
Earnings Date Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 20,000
Stock Exchange Vienna Stock Exchange
Ticker Symbol SDZ
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.